Personalized Treatment of Colorectal Cancer

Publisher： Karger

E-ISSN： 2296-5262|35|1|42-48

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.35, Iss.1, 2012-01, pp. : 42-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolomic profiling in colorectal cancer: opportunities for personalized medicine

By Zheng Xiaojiao Xie Guoxiang Jia Wei

Personalized Medicine, Vol. 10, Iss. 7, 2013-09 ,pp. : 741-755

Future Medicine

Access to resources Recommend Favorite

Pharmacogenomic biomarkers for personalized cancer treatment

JOURNAL OF INTERNAL MEDICINE, Vol. 277, Iss. 2, 2015-02 ,pp. : 201-217

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valuing personalized medicine: willingness to pay for genetic testing for colorectal cancer risk

By Van Bebber Stephanie L Liang Su-Ying Phillips Kathryn A Marshall Deborah Walsh Judith Kulin Nathalie

Personalized Medicine, Vol. 4, Iss. 3, 2007-08 ,pp. : 341-350

Future Medicine

Access to resources Recommend Favorite

Drug approval challenges in the age of personalized cancer treatment

By Schilsky Richard L

Personalized Medicine, Vol. 8, Iss. 6, 2011-11 ,pp. : 633-640

Future Medicine

Access to resources Recommend Favorite

Costs of chemotherapy in the treatment of colorectal cancer

By Jansman F. Postma M.

The European Journal of Health Economics, Vol. 7, Iss. 2, 2006-06 ,pp. : 145-146

Springer Publishing Company

Access to resources Recommend Favorite